Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.

Preventive Medicine
Margaret W Cavanaugh-HusseyDonald Lloyd-Jones

Abstract

We sought to determine the levels of risk factors required to exceed threshold values of intermediate (> or = 10%) or high (> 20%) predicted 10-year risk for coronary heart disease using the Adult Treatment Panel III (ATP-III) Risk Assessment Tool. Continuous risk factor values were entered into the risk assessment tool to examine levels of predicted 10-year risk. Both individual risk factors and the joint effects of varying multiple risk factors were systematically examined. Women only exceed 10% risk at ages > or = 70 with single risk factors of HDL-cholesterol levels < 30 mg/dL or systolic blood pressure > 170 mm Hg. Women < or = 65 only exceed 10% risk if they are smokers with low HDL-cholesterol levels. In contrast, single risk factors can cause men over 45 to exceed 10% or 20% predicted 10-year risk. Combinations of only modestly elevated risk factors cause many men to exceed 10% risk at ages > or = 45, and to exceed 20% risk at ages > or = 55. Because such high-risk factor levels are required for men < 45 years and women < 65 years to exceed ATP-III risk thresholds, additional means for risk communication may be needed for individuals with elevated risk factors in these age ranges.

References

May 29, 1998·Circulation·P W WilsonW B Kannel
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jul 13, 2001·JAMA : the Journal of the American Medical Association·R B D'AgostinoUNKNOWN CHD Risk Prediction Group
Apr 6, 2002·BMJ : British Medical Journal·Adrian EdwardsAl Mulley
Sep 10, 2003·Archives of Internal Medicine·Donald M Lloyd-JonesDaniel Levy
Jun 29, 2004·The American Journal of Cardiology·Donald M Lloyd-JonesDaniel Levy
Sep 11, 2004·Journal of the American College of Cardiology·Scott M GrundyUNKNOWN Coordinating Committee of the National Cholesterol Education Program
Oct 7, 2004·JAMA : the Journal of the American Medical Association·Martha L DaviglusPhilip Greenland
Feb 9, 2005·Circulation·Ramachandran S Vasan, Ralph B D'Agostino
Mar 16, 2005·Annals of Internal Medicine·Ramachandran S VasanRalph B D'Agostino
Aug 16, 2006·Preventive Medicine·Stephen D PersellDavid W Baker
Jun 23, 2007·American Heart Journal·Jarett D BerryPhilip Greenland
Mar 7, 2008·Lancet·Allan D Sniderman, Curt D Furberg

❮ Previous
Next ❯

Citations

Dec 22, 2011·Journal of Atherosclerosis and Thrombosis·Hyo Eun ParkDae-Won Sohn
Feb 18, 2010·Circulation. Cardiovascular Quality and Outcomes·Judith HsiaUNKNOWN Women's Health Initiative Research Group
Jul 27, 2011·The International Journal of Cardiovascular Imaging·Hyo Eun ParkByung-Hee Oh
Jan 20, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Anthony S Wierzbicki, Adie Viljoen
Apr 30, 2011·Preventive Medicine·Panniyammakal Jeemon
Dec 3, 2010·Journal of Clinical Lipidology·Jennifer G Robinson, Benjamin Booth
Jan 7, 2009·Preventive Medicine·Kelly H SchlendorfRoger S Blumenthal
Dec 25, 2015·Journal of Clinical Lipidology·Terry A JacobsonUNKNOWN NLA Expert Panel
Nov 14, 2013·Journal of the American Pharmacists Association : JAPhA
Sep 24, 2010·Preventive Cardiology·John T Wilkins, Donald M Lloyd-Jones
Jul 7, 2014·American Journal of Preventive Medicine·Shikhar AgarwalVenu Menon
Sep 6, 2014·Journal of the American College of Cardiology·Kunal N KarmaliDonald M Lloyd-Jones
Sep 26, 2009·Journal of the American College of Cardiology·Marie Therese CooneyIan M Graham
Mar 11, 2011·Journal of the American College of Cardiology·Lori MoscaUNKNOWN American Heart Association
Oct 29, 2013·International Journal of Vascular Medicine·S Monira HussainAndrew M Tonkin
Jul 10, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Heba AlwanPascal Bovet
Oct 1, 2014·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Benjamin J GrayUNKNOWN Prosiect Sir Gâr Group
Dec 19, 2009·Circulation·UNKNOWN WRITING GROUP MEMBERSUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Dec 17, 2010·Circulation·Véronique L RogerUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Dec 20, 2011·Circulation·Véronique L RogerUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Nov 26, 2010·Circulation·Philip GreenlandUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Jan 9, 2013·Nature Reviews. Cardiology·Kunal N Karmali, Donald M Lloyd-Jones
Sep 7, 2019·The Lancet Global Health·Farshad Farzadfar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.